Recruiting NA Hemophilia a

New treatment option for Hemophilia a

Official title Measurement Properties in People with Hemophilia

ClinicalTrials.gov ID: NCT06565481

What this study is testing

What it's testing
The aim of this project is to determine the measurement properties (namely reliability and validity) of a set of clinical assessments, measuring different aspects of physical function.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Diagnosed Hemophilia Types A or B
  • Adult people ≥ 18 years
  • Patients on prophylactic factor or non-factor replacement treatment, or on demand factor replacement treatment.
  • Able to walk for 20 meters independently, with or without walking aid
  • Signed informed consent to participate in the study

You likely can't join if

  • Severe health conditions like severe cardiovascular, pulmonary, neurological or musculoskeletal diseases.
  • Unable to perform the assessments due to disability or language problems.

The study team makes the final eligibility decision.

Where it's taking place

  • Zurich, Switzerland

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Zurich, Switzerland. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.